← Back to Browse
Ask AleraHome
CT
MultisystemDemonstration data

Dual-Energy CT

Dual-energy CT (DECT) acquires data at two distinct photon energies, allowing material decomposition based on energy-dependent attenuation differences. Clinical applications include monosodium urate detection in gout, renal stone characterisation, iodine quantification, virtual monoenergetic imaging and virtual non-contrast reconstructions that can reduce radiation dose.

Indications

  • Detection and mapping of monosodium urate deposits in suspected or known gout
  • Renal calculus composition analysis, especially uric acid versus calcium-based stones
  • Iodine quantification to confirm or exclude true lesion enhancement (e.g. renal masses, pulmonary embolism perfusion)
  • Virtual non-contrast imaging to eliminate a separate pre-contrast acquisition
  • Metal artefact reduction and beam-hardening correction using virtual monoenergetic images

Contraindications & Cautions

  • Standard iodinated contrast contraindications for contrast-enhanced applications (allergy, renal impairment)
  • Very large body habitus that may exceed high-kV photon penetration and degrade material separation
  • Situations where single-energy CT fully answers the clinical question (avoid unnecessary complexity)

Patient Preparation

  • Preparation as per the underlying clinical protocol (e.g. hydration and contrast screening for enhanced studies)
  • No specific patient preparation for non-contrast gout or stone applications beyond standard positioning
  • Confirm scanner-specific dual-energy mode and reconstruction pipeline are available
  • Position the region of interest within the dual-energy field of view for dual-source systems

Technique & Parameters

  • Dual-energy acquisition via dual-source (e.g. 80/Sn150 kV), rapid kV switching, or dual-layer detector
  • Material decomposition into basis pairs (e.g. iodine-water, calcium-uric acid)
  • Reconstruct virtual monoenergetic images (typically 40-70 keV) to optimise contrast or reduce artefact
  • Generate iodine maps, virtual non-contrast series and colour-coded urate overlays as indicated
  • Apply gout-specific post-processing thresholds to avoid artefactual urate labelling

Systematic Review

  • Confirm appropriate material decomposition pair for the clinical question
  • For gout, review colour-coded urate maps and correlate with the target joints
  • For stones, categorise composition using the uric acid versus calcium decomposition
  • For enhancement, use the iodine map and quantify iodine concentration (mg/mL)
  • Check virtual non-contrast images against material maps for internal consistency

Key Findings & Significance

  • Green (or vendor-defined) colour-coded monosodium urate deposits around joints and tendons in gout
  • Uric acid stones decompose distinctly from calcium oxalate/phosphate stones, guiding therapy
  • Iodine map demonstrating true enhancement in a renal or hepatic lesion
  • Reduced perfused blood volume defect on pulmonary iodine maps in acute pulmonary embolism
  • Improved delineation of hypervascular lesions on low-keV virtual monoenergetic images

Differential Considerations

  • Artefactual urate coding (nailbed, skin, submillimetre and beam-hardening artefact) versus true tophi
  • Uric acid versus calcium-containing calculi
  • True enhancement versus pseudoenhancement in renal cysts
  • Haemorrhage versus iodinated contrast on virtual non-contrast material maps
  • Calcium versus iodine differentiation in vascular and osseous structures

Pearls & Pitfalls

  • Recognise gout urate artefacts (skin, nailbed, beam hardening) to avoid false-positive diagnosis
  • Iodine quantification thresholds help distinguish enhancing solid masses from hyperdense cysts
  • Low-keV virtual monoenergetic images boost iodine contrast; high-keV images reduce metal artefact
  • Virtual non-contrast can replace a true non-contrast phase, lowering dose, but may miss small calcifications

Structured Report

  • State the dual-energy application performed and the decomposition technique used
  • Report urate distribution and volume/burden for gout, noting excluded artefacts
  • Report stone composition and Hounsfield/energy behaviour for urolithiasis
  • Provide iodine concentration values to support enhancement conclusions
  • Document any dose-saving virtual non-contrast substitution and its limitations

References

  • Radiographics: McCollough CH et al. Dual- and Multi-Energy CT: Principles, Technical Approaches, and Clinical Applications
  • ACR-SPR Practice Parameters relevant to CT material characterisation
  • Radiographics: Mallinson PI et al. Dual-Energy CT for the Musculoskeletal System
  • Marin D et al. State of the Art: Dual-Energy CT of the Abdomen, Radiology

Educational clinical decision support only. Protocols vary by institution and equipment; always confirm with a qualified radiologist and local guidelines before clinical use.